Amphastar Pharmaceuticals, Inc. — Director's Dealing 2017

Jun 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2017-06-08

Reporting Person: Petersen Floyd F. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-08	Common Stock	A	5844	—	Acquired	64561	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-08	Stock Option (right to buy)	$17.11	A	20291	Acquired	2022-06-08	Common Stock (20291)	Direct

Footnotes

F1: The reported securities are represented by restricted stock units, or RSUs, all of which vest on June 8, 2018.

F2: All of the shares subject to the option vest on June 8, 2018.